Rosetta Genomics Ltd. (ROSG) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts ROSG Hot Sheet
Join SI Premium – FREE
Rosetta Genomics Ltd. (NASDAQ: ROSG) reported Q1 non-GAAP loss of ($0.08), $0.14 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $37 thousand versus the consensus estimate of $27 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
